Bell Medical Solutions

Bell Medical Solutions was a prominent Japanese Contract Research Organization (CRO) that provided comprehensive clinical development services to the pharmaceutical and biotechnology industries. The company specialized in Phase I through IV clinical trial management, offering expertise in clinical monitoring, data management, statistical analysis, and randomization services. It was particularly recognized for its strategic alliance with inVentiv Health (now Syneos Health), which facilitated global clinical trials and helped international sponsors navigate the Japanese regulatory landscape. In 2017, the company's CRO operations were acquired by A2 Healthcare Corporation, a subsidiary of ITOCHU Corporation, and integrated into their clinical research platform.